Opaleye Management Inc.'s Form 4 filing
Protara Therapeutics, Inc. (TARA) · filed Sep 15, 2022
- Accession no.
- 0001493152-22-025978
- Filed
- Sep 15, 2022
- Trade date
- Sep 14-15, 2022
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 4 non-derivative transactions and 0 derivative transactions. Open-market purchases total $93.8K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Opaleye Management Inc.CIK 0001595855 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 14, 2022 | Common Stock, par value $0.001 per share | PPurchaseAcquired | +14,100 | $3.98 | +$56,118 | 2,570,777 | Indirect | |
| Sep 14, 2022 | Common Stock, par value $0.001 per share | PPurchaseAcquired | +2,500 | $3.98 | +$9,950 | 130,000 | Indirect | |
| Sep 15, 2022 | Common Stock, par value $0.001 per share | PPurchaseAcquired | +5,000 | $3.80 | +$19,000 | 2,575,777 | Indirect | |
| Sep 15, 2022 | Common Stock, par value $0.001 per share | PPurchaseAcquired | +2,300 | $3.80 | +$8,740 | 132,300 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.